Development

Drugs designed for other diseases keep turning out to slow aging

development2026-06-08

Claim

Colchicine, built for gout, is now cutting cardiac events 22%, the shingles vaccine is slowing cognitive decline, GLP-1 drugs are tied to lower breast cancer incidence, and retatrutide cut sleep apnea severity 60.6% and knee pain over 70% atop roughly 30% weight loss.

Reported metric: -60.6% apnea / -70% knee pain

Reporting date: 2026-06-08 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to June 8, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to June 8, 2026

Actor

Eli Lilly

Evidence for

Supersedes

A GLP-1 drug slows biological aging in a controlled trial

Referenced by

Cite or correct this record

Citation formatCitation text

Drugs designed for other diseases keep turning out to slow aging
Innermost Loop KB — secondary record
Reporting date: 2026-06-08
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-06-08-drugs-built-for-something-else
Claim: Colchicine, built for gout, is now cutting cardiac events 22%, the shingles vaccine is slowing cognitive decline, GLP-1 drugs are tied to lower breast cancer incidence, and retatrutide cut sleep apnea severity 60.6% and knee pain over 70% atop roughly 30% weight loss.
Attributed sources:
- Welcome to June 8, 2026 — https://theinnermostloop.substack.com/p/welcome-to-june-8-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.